Glucose monitoring in acute pancreatitis
Part of Digestive system, Hormones & metabolism clinical trials.
This study watches blood sugar levels in people hospitalized with acute pancreatitis. It checks if low insulin and gut bacteria affect sugar levels, and uses a small sensor on the skin (continuous glucose monitor) to track sugar without frequent finger pricks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be in the hospital with a diagnosis of acute pancreatitis (sudden inflammation of the pancreas).
- You need to be able to give consent in English.
- You must not have diabetes or be on insulin therapy before this hospital stay.
- You must not be pregnant.
- You must not have an allergy to the adhesive used in continuous glucose monitors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing two ways of monitoring blood sugar in intensive care patients: continuous monitoring (a sensor) versus intermittent checks. If you are in the ICU with high blood sugar and on IV insulin, this study might help find a better way to manage your levels.
This study tests a small sensor called a continuous glucose monitor (CGM) that tracks your blood sugar after kidney transplant. It helps doctors see how your body handles sugar during recovery.
This study looks at how acute pancreatitis affects blood sugar and the risk of developing diabetes. You'll wear a continuous glucose monitor (CGM) sensor and have metabolic tests to track changes over time.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This trial tests whether using a continuous glucose monitor (CGM) when you leave the hospital helps control blood sugar better. If you have type 2 diabetes and use insulin, you may be able to join.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
Hear when a new Hyperglycaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.